nedaplatin has been researched along with Kidney Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuhara, H; Inoue, K; Kamada, M; Matumoto, M; Nishikawa, H; Shuin, T; Tamura, K; Yamasaki, I | 1 |
| Fukuta, F; Kitamura, H; Kunishima, Y; Masumori, N; Mutoh, M; Shigyo, M; Taguchi, K; Takahashi, A; Tanaka, T; Tsukamoto, T; Yanase, M | 1 |
| Fujikawa, N; Hattori, Y; Kakizoe, M; Kishida, T; Kondo, K; Kubota, Y; Nakaigawa, N; Noguchi, K; Saito, K; Takizawa, A; Teranishi, J | 1 |
| Kubota, Y; Makiyama, K; Nakaigawa, N; Oshiro, H; Sugiura, S; Yao, M | 1 |
1 review(s) available for nedaplatin and Kidney Neoplasms
| Article | Year |
|---|---|
[Granulocyte-colony stimulating factor producing squamous cell carcinoma of the renal pelvis: a case report].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Deoxycytidine; Female; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Kidney Neoplasms; Kidney Pelvis; Organoplatinum Compounds | 2010 |
1 trial(s) available for nedaplatin and Kidney Neoplasms
| Article | Year |
|---|---|
Paclitaxel, ifosfamide, and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: a phase II study of the SUOC group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Ifosfamide; Kidney Neoplasms; Kidney Pelvis; Male; Middle Aged; Organoplatinum Compounds; Paclitaxel; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms | 2011 |
2 other study(ies) available for nedaplatin and Kidney Neoplasms
| Article | Year |
|---|---|
[Clinical study of combination chemotherapy of methotrexate, epirubicin and nedaplatin (MEN) in patients with advanced urothelial carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Drug Administration Schedule; Epirubicin; Female; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Organoplatinum Compounds; Quality of Life; Remission Induction; Survival Rate; Urinary Bladder Neoplasms | 2007 |
Collecting duct carcinoma producing granulocyte-colony-stimulating factor (G-CSF).
Topics: Aged; Antineoplastic Agents; Combined Modality Therapy; Deoxycytidine; Fatal Outcome; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Kidney Neoplasms; Kidney Tubules, Collecting; Lung Neoplasms; Male; Nephrectomy; Organoplatinum Compounds; Radiography | 2007 |